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ABSTRACT 
Objective: The present study was planned to develop a mucoadhesive tablet formulation of the drug pentoxifylline using natural mucoadhesive 
polymer from the plant Ocimum basilicum Linn. 
Methods: The isolated polymer was used to formulate the mucoadhesive tablets with 3 different concentrations. The tablets were formulated by 
using direct compression technique and evaluated for various parameters such as thickness, friability, weight variation, hardness, mucoadhesive 
strength, swelling index by standard methods, and the in vitro drug release studies in USP dissolution test apparatus type-II. 
Results: The swelling index was indirectly proportional to the polymer concentration and the tablets with a high concentration of polymer showed 
better mucoadhesive strength (28.5532±0.4660). The in vitro drug release showed that the drug release was indirectly proportional to the polymer 
concentration. The formulation F3 showed the controlled release of drug pentoxifylline (99.84±1.86) for 10 h. The mechanism of drug release was 
found to be Fickian diffusion and followed the zero-order kinetics, which was proved by its highest linearity (r2
Conclusion: The tablets formulated with the isolated polymer of Ocimum basilicum Linn showed the good mucoadhesive mucoadhesive property 
and it controlled the release of the pentoxifylline.  
) in all the formulations.  
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Naturally acquired mucoadhesive polymers are gaining much 
attention in the development of various pharmaceutical dosage 
forms [1]. Bioadhesion, as a state in which two materials, at least one 
of which being of biological nature are held together for an extended 
period of time by interfacial forces [2]. It is also defined as the ability 
of a material (synthetic or biological) to adhere to a biological tissue 
for an extended period of time [3, 4]. Mucoadhesion is an obverse of 
bioadhesion, which is aimed to target the drugs to a particular 
mucosal area of the body. The polymers, those are water-soluble and 
become adhesive during hydration were used to formulate the 
mucoadhesive dosage forms. The mucoadhesive dosage forms are 
aimed to target the drug with increased gastric residence time, 
sustained/controlled release, minimized the first-pass effect and 
reduced adverse effects [5, 6]. The mucoadhesive polymers selected 
should be non-toxic, non-irritant, non-absorbable, non-covalent, 
biocompatible, adhesive and economic in nature [7]. Either natural 
(gelatin, guar gum and sodium alginate) or synthetic/semi-synthetic 
(Hydroxypropyl methylcellulose, Carbopol 934 and Sodium carboxy 
methyl cellulose), may be used alone or in a combination of two or 
more for the mucoadhesive drug delivery systems [8–12]. 
Ocimum basilicum Linn. (OBL) is an erect, almost glabrous herb, 
belonging to the Lamiaceae family, native to Iran, Afghanistan and 
India, which grows to between 30 and 90 cm high. The leaves are 
ovate, lanceolate, cucuminate, toothed or entire, glabrous on both 
surfaces and glandular. When mature, they reach approximately 5 
cm in length, excluding the petiole, which is approximately 2 cm 
long. The upper surface is smooth and lustrous; on the lower 
surface along the midrib and the petiole short, stiff hairs occur 
sparingly [13]. It represents an important source of essential oil 
used in food, pharmaceutical, perfumery and cosmetics industries 
[14]. Its aromatic leaves are used in fresh or dried forms as a drug 
in traditional medicine and as a flavoring agent in food and 
confectionery products as well as beverages [13, 15]. The seeds of 
OBL 
Bhosale et al. [17] investigated the hydrogel isolated from the seeds of 
OBL as a binder and proved that it has potential binding and 
granulating property. Khazaei et al. [18] characterized the new 
biodegradable edible film made from OBL seed gum and revealed that 
it had a good potential to be used in producing edible films for various 
food applications. Akbari et al. [19] used supercritical carbon dioxide 
phase inversion technique to dry the seed mucilage to form a 
nanometric structure and they found the bioadhesive property of seed 
mucilage was good and many active pharmaceutical compounds might 
be loaded to the resultant nanometric structure to enhance drug 
release. Naji-Tabasi et al. [20] evaluated the potential of OBL seed gum 
nanoparticles as an oral delivery system for glutathione, which was 
fabricated by ion gelling technique and calcium was used as a cross-
linking agent. A novel drug delivery system, loaded the drug 
cephalexin on the OBL seed mucilage coated magnetic nanoparticles 
was prepared and characterized by Rayegan et al. [21].  
are high in fiber (22.6%) and in some regions of Asia like Iran 
and India, basil seeds are frequently included in beverages and 
desserts for aesthetic purposes as well as a source of dietary fiber 
[16]. 
Even though several advances and researches have been made in the 
area of mucoadhesion and polymers, still the search for newer 
mucoadhesives are going on. Plant-derived polymers like mucilage 
are widely used in the pharmaceutical industry due to their 
emollient, lack of toxicity, and low cost. So, in this present work, an 
attempt was made to study the application of novel natural 
mucoadhesive polymer from the plant Ocimum basilicum (MAPOB) 
in the development of pentoxifylline mucoadhesive tablets concern 
to the in vitro drug release rate. 
MATERIALS AND METHODS 
Materials 
The seeds of Ocimum basilicum were purchased from the local vendors 
of Chennai, Tamilnadu in the month of February 2018. The collected 
seeds were identified and authenticated by a botanist Dr. S. 
Balasubramanian, ABS Medicinal garden, Salem. The voucher specimen 
(OBG-1) was kept in our museum for future reference. Pentoxifylline 
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was obtained as a gift sample from Shasun Pharmaceuticals, Puducherry. 
Microcrystalline cellulose and magnesium stearate were purchased from 
Central Drug House (India). Acetone, diethyl ether and petroleum ether 
were from Qualigens (India) and sodium hydroxide from E-Merck 
(India). All the chemicals used were of analytical grade. 
Methods 
Isolation of MAPOB 
Three batches of MAPOB was prepared on a laboratory scale by the 
method of Rao et al. [22]. 200 ml of cold distilled water was added to 
20 g of the seed powder and the slurry was prepared. Then the slurry 
was added to 800 ml of boiling water and boiled for another 20 min 
with continuous stirring. The solution was kept overnight to settle the 
solid matter. The clear solution was centrifuged for 20 min at 5000 
rpm. The supernatant fluid was separated and twice the volume of 
acetone was added with continuous stirring. The formed precipitates 
were filtered and washed with petroleum ether and diethyl ether and 
then dried under vacuum at 50-60 ° C. The dried materials were sieved 
through sieve No 80 and used for the formulation of tablets.  
Formulation of mucoadhesive tablets 
The mucoadhesive tablets of pentoxifylline (MATP) were prepared 
by using direct compression technique. Pentoxifylline, 
mucoadhesive polymer, microcrystalline cellulose, magnesium 
stearate were accurately weighed, mixed uniformly and this mixture 
was compressed into tablets by using Elite multi-station punching 
machine (Erweka) with 10 mm flat punches. The compression force 
was adjusted to give tablet hardness in the range of 7 to 11 kp. The 
constituent of the formulation is presented in table 1. 
 
Table 1: Formulation of mucoadhesive tablets of pentoxifylline 
Ingredients F1 F2 F3 
Pentoxifylline 400 400 400 
Microcrystalline cellulose 152 122 92 
MAPOB 30 60 90 
Magnesium stearate 18 18 18 
Total weight (mg) 600 600 600 
All the quantities are in mg 
 
Swelling study 
The formulated MATP’s were weighed (W1) individually and 
incubated at 37±0.5 ° C separately in an agar gel (2%) plates The 
tablets were removed from petri dish at regular time intervals of 1 h 
up to 6 h and the excess water on the surface was removed carefully 
with filter paper. The swollen tablet was reweighed (W2) and the 






The mucoadhesive strength (MS) of the formulated MATP’s was 
measured by using a modified 2-arm balance (fig. 1) with rabbit 
buccal mucosa [26]. The apparatus consists of a modified double 
beam physical balance in which the right pan has been replaced by a 
glass slide with copper wire and additional weight, to make the right 
side weight equal with left side pan. A Teflon block of 3.8 cm 
diameter and 2 cm height was fabricated with an upward protrusion 
of 2 cm height and 1.5 cm diameter on one side. This was kept in a 
beaker filled with phosphate buffer (PB) pH 6.8, which was then 
placed below the right side of the balance. 
The rabbit buccal mucosa was used as the membrane and PB pH 
6.8 as moisturizing liquid. The rabbit buccal mucosa was obtained 
from the local slaughterhouse and stored in Krebs buffer at 4 °C 
upon collection. The experiment was conducted within 3 h of the 
procurement of rabbit mucosa. The mucous layer was separated 
by using a surgical blade and washed with PB pH 6.8. It was then 
tied over the protrusion in the Teflon block using a thread. This set 
was kept in a glass beaker, which was filled with PB pH 6.8 up to 




Fig. 1: Mucoadhesive strength measurement apparatus 
 
The MATP was attached to the upper clamp of the apparatus and 
then the beaker was raised slowly until contact between rabbit 
buccal mucosa and MATP was established. A weight of 100 g was 
kept on the clamp for a pre-load time of 5 min to create a strong 
adhesion between rabbit buccal mucosa and the MATP. The pre-load 
and pre-load time were kept as constant for all the MATP’s. After the 
pre-load time, the weight was removed from the clamp, and water 
was added at a rate of 60 drops/min into the beaker until the 
separation of rabbit buccal mucosa and MATP. The weight of water 
required to detach the MATP from buccal mucosa was noted as MS 
and the same was repeated with fresh mucosa (n = 6). The MS was 
used to calculate the force of adhesion [25, 27–29] using formula. 
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In vitro drug release studies 
The in vitro dissolution studies were carried out in Type-II USP 
dissolution test apparatus, using 900 ml of phosphate buffer saline 
(PBS) pH 6.8. The dissolution test was carried out at a speed of 50 
rpm and the temperature was maintained at 37 °C±0.5 °C. 5 ml of 
the sample was withdrawn periodically at predetermined time 
intervals and assayed spectrophotometrically at 274 nm using 
Shimadzu UV spectrophotometer 1601. All the experiments were 
done thrice and the standard curve specification was y=0.0392X (r2
Each experiment was repeated at least three times. The results are 
expressed as mean±SD. One-way analysis of variance was used to 
test the statistical significance of differences among groups. 
Statistical significance of the differences of the means was 
determined by Student’s t-test. 
 
= 0.9993, n = 10). 
Drug release kinetics 
The data obtained from in vitro release of drug was plotted in 
various kinetic models such as zero-order (cumulative amount of 
drug released vs time), first-order (log cumulative percentage of 
drug remaining vs time), and Higuchi’s model (cumulative 
percentage of drug released vs square root of time) to know the 
release kinetics [30–32]. 
Mechanism of drug release 
The mechanism of drug release of the prepared MATP was 
calculated by using Korsmeyer equation (log cumulative percentage 
of drug released vs log time), and the exponent n was calculated 
through the slope of the straight line [33]. 
Statistical analysis  
RESULTS AND DISCUSSION 
Polymers are most commonly used as an adjuvant in the 
manufacturing of different pharmaceutical dosage forms. They 
possess a variety of pharmaceutical properties, which include 
binding, disintegrating, suspending, emulsifying and sustaining 
properties at different proportion in different pharmaceutical 
dosage forms [34, 35]. But in the view of biodegradation and 
biocompatibility, the natural polymers are preferred. Even though 
many polymers are available, a search for new polymers still 
interesting to get more efficacious polymers with less toxic. The 
purpose of this research is to give scientific validation to the plant by 
isolating polysaccharides and then to screen them for the potential 
mucoadhesive property. The current research work is focused on 
the identification of a new mucoadhesive polymer and its 
application on the development of pentoxifylline mucoadhesive 
tablets 
The plant OBL was selected for this study and the mucilage was 
isolated from the seeds by the method of Rao et al., [22]. Three 
different concentrations of MAPOB was used to formulate 
mucoadhesive tablets of pentoxifylline. The formulated tablets 
showed a satisfactory evaluation report on hardness, friability, 
weight variation and drug content. The results were shown in table 
2. The increase in concentration [25, 36] of the mucoadhesive 
polymer, increased the tablet hardness. 
 
Table 2: Results of evaluation of thickness, hardness, friability weight variation and drug content for mucoadhesive formulations 






Weight variation (mg±%) Drug content  
(%±SD) 
F1 6.259±0.022 68.649±4.004 0.2394±0.0895 0.6004±1.81 100.11±4.57 
F2 6.266±0.024 73.553±4.623 0.2391±0.0194 0.5990±1.79 99.08±4.33 
F3 6.249±0.029 79.4367±5.064 0.2053±0.1018 0.5992±2.16 100.78±2.48 
(All values are mean±SD; n=6) 
 
An appropriate swelling index is mandatory for the uniform and 
sustained release of the drug and effective mucoadhesion [25, 36]. The 
results of the swelling study showed that the rate of swelling was 
indirectly proportional to the concentration of MAPOB in tablets. The 
tablets formulated (F1) with a lower concentration of MAPOB showed 
a high swelling index (5.038±0.182), and the formulation (F3) with a 
higher concentration of MAPOB showed lower swelling index 
(3.334±0.087). Formulations F2 and F3 were showed no significant 
change in the shape and form of tablets for a period of up to 6 h, when 
they kept in the agar gel (2%) plate, but the formulation F1 changed 
the shape and form completely. The results of the swelling index have 
been tabulated in table 3
 
. The tablets, which had high swelling index 
described that the formation of a gel by the hydration of the polymer, 
did not have good adhesion, probably due to overhydration resulting 
less MS. The formulation F3 tablets adhered well to the agar gel plates 
and a layer of gel was seen adhering to the sides of the tablets. This 
suggests that the gel formed was firm and there was no overhydration, 
making the tablets adhere well to the plates. 
Table 3: Results of swelling index, mucoadhesive strength and force of adhesion 
S. No. Formulation Swelling index (±SD) Mucoadhesive strength (g±SD) Force of adhesion (Newton±SD) 
1 F1 5.038±0.182 9.3566±0.0866 0.9179±0.0085 
2 F2 4.471±0.120 19.7506±0.5695 1.9375±0.0599 
3 F3 3.334±0.087 28.5532±0.4660 2.8011±0.0457 
(All values are mean±SD; n=6) 
 
MS of MATOB with rabbit buccal mucosa is shown in table 3. 
Wetting, interpenetration, and mechanical interlocking between 
mucus and polymer were the three different stages of occurrence of 
the mucoadhesion. The MS is affected by various factors such as 
polymer’s swelling rate, molecular weight [37], contact time with 
mucus, and the biological membrane used for the study [38]. Tablets 
formulated with a high concentration of MAPOB showed good MS in 
a contact time of 5 min. This high MS of MAPOB may be due to the 
formation of secondary bioadhesion bonds with mucin and 
interpenetration of the polymer chains in the interfacial region. 
However, the formulations F1, F2 and F3 exhibited MS of 
9.3566±0.0866, 19.7506±0.5695 and 28.5532±0.4660 g, 
respectively, with rabbit buccal mucosa. 
The in vitro drug release studies (fig. 2) were carried out and the 
results showed that the release of the drug from the formulated 
tablets were based on the MAPOB concentration. The formulation 
F1, which has a high swelling index, becomes gel-like due to the over 
hydration of polymer, leads to more % of drug diffused from the 
polymer matrix [39]. The % of drug release (99.03±2.58) was more 
in formulation F1 but it was within a period of 4 h. The % of drug 
release was decreased gradually to 99.96±2.31 at 8 h for the 
formulation F2 and 99.84±1.86 at 10 h for the formulation F3. This 
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extend of time-release may be due to the increase in the 
concentration of MAPOB. It may be due to the in situ gelling 
property of mucoadhesive polymer, which slows the dissolution. 
Tablets of batch F3 was remaining intact during the entire 10 h 




Fig. 2: The cumulative release profile of mucoadhesive tablets of pentoxifylline formulated with MAPOB. (mean±SD; n=3) 
 
The zero-order release described that the release rate is dose-
independent, which shows the cumulative amount of drug release vs 
time for zero-order kinetics. The first order release described the 
release rate is dose-dependent, which shows the log cumulative 
percent drug remaining vs time [40]. Higuchi’s model described the 
release of drugs from an insoluble matrix as a square root of a time-
dependent process based on Fickian diffusion. Higuchi square root 
kinetics, showing the cumulative percent drug release vs the square 
root of time [41]. The release constant was calculated from the slope 
of the appropriate plots, and the regression coefficient (r2) was 
determined (table 3). It was found that the in vitro drug release of 
mucoadhesive tablets of pentoxifylline was following zero-order 
release, as the plot showed the highest linearity (r2=0.9693, 0.9761 
and 0.9731) for the formulations, F1, F2 and F3 respectively), and 
Higuchi’s (r2
 
=0.9887, 0.9953 and 0.9896), which indicates the 
release rate was not depending upon the dose of the drug. 
Table 3: Release kinetics of mucoadhesive tablets of pentoxifylline 
Formulation First order Zero-order Higuchi Korsmeyer Peppas 
Slope r Slope 2 r Slope 2 r Slope 2 r2 
F1 0.543 0.9197 25.999 0.9693 69.229 0.9887 0.8502 0.9772 
F2 0.1675 0.9614 12.892 0.9761 45.795 0.9953 0.8807 0.9842 
F3 0.1313 0.9626 10.805 0.9731 41.794 0.9896 0.9357 0.9892 
The corresponding Korsmeyer-Peppas [39] plot (log cumulative percent drug release vs time) indicated good linearity (r2
 
=0.9772, 0.9842 and 
0.9892) and showed the matrix release of the drug pentoxifylline.  
CONCLUSION 
The polymers are playing an important role in the field of controlled 
or sustained release drug delivery system. Since the seeds of the 
plant, OBL has rich mucilage content and that may prove to be an 
alternative to existing mucoadhesive polymers. Therefore, in the 
present study, an attempt was made to study the application of a 
novel mucoadhesive polymer isolated from the plant OBL for the 
development of pentoxifylline mucoadhesive tablets. The patient 
compliance may be increased, when the dosing frequency of the 
drug reduced. The tablets formulated with MAPOB showed the 
controlled release of pentoxifylline for a period of 10 h. The in vitro 
dissolution studies indicated that the drug pentoxifylline was 
released in zero-order pattern, as the plot showed the highest 
linearity. It also indicates that the increasing concentration of the 
polymer leads to a decrease in the release rate and increasing the 
mucoadhesive strength of the tablet.  
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